Abstract
Among gliptins, linagliptin is unique, because decreased glomerular filtration rate does not require dose reduction. Linagliptin was originally developed to lower blood glucose by inhibiting dipeptidyl peptidase-4 (DPP-4). However, DPP-4 has numerous additional substrates, and thus gliptins possess a vast range of additional off-target effects. Shi et al. report that linagliptin directly targets interaction of DPP-4 with integrin β1, preventing endothelial-mesenchymal transition and ultimately renal fibrosis, providing additional rationale for use of linagliptin in diabetic nephropathy.
References
Jul 31, 2007·Nature Medicine·Elisabeth M ZeisbergRaghu Kalluri
Jan 29, 2008·The Journal of Pharmacology and Experimental Therapeutics·Leo ThomasMichael Mark
Nov 7, 2008·Journal of the American Society of Nephrology : JASN·Elisabeth M ZeisbergRaghu Kalluri
Aug 3, 2012·Fibrogenesis & Tissue Repair·Ling XuDaisuke Koya
Feb 28, 2014·Diabetes·Keizo KanasakiDaisuke Koya
Apr 1, 2014·Fibrogenesis & Tissue Repair·Federica GenovesePeter Boor
Jul 10, 2014·Kidney International·Tetsuhiro TanakaMasaomi Nangaku
Oct 16, 2014·World Journal of Diabetes·Ioannis Ioannidis
Citations
Feb 16, 2016·Fibrogenesis & Tissue Repair·Sen ShiKeizo Kanasaki
Jan 31, 2016·Biochemical and Biophysical Research Communications·Sen ShiDaisuke Koya
Apr 20, 2017·Journal of Molecular Endocrinology·Ahmed A Hasan, Berthold Hocher
Apr 15, 2018·Current Diabetes Reports·Scott C Thomson, Volker Vallon
Mar 2, 2018·Clinical Science·Keizo Kanasaki
Sep 5, 2017·Nature Reviews. Nephrology·Marcel H A MuskietDaniël H van Raalte
Oct 27, 2016·Plastic and Reconstructive Surgery·Michael S Hu, Michael T Longaker
May 24, 2018·Laboratory Investigation; a Journal of Technical Methods and Pathology·Jian XuHui Kong
Aug 31, 2017·The New England Journal of Medicine·Johannes F E MannUNKNOWN LEADER Steering Committee and Investigators
May 4, 2018·Heart and Vessels·Tazuru IgarashiJunya Ako
Aug 3, 2016·Diabetology International·Keizo Kanasaki
Jan 31, 2021·Communications Biology·Yi-Chen LiChih-Chao Yang
Jan 30, 2021·Kidney International·Masaomi Nangaku, Christoph Wanner
Jul 30, 2020·Canadian Journal of Physiology and Pharmacology·Maaly Abd ElmaaboudShahinaz Shalaby
Apr 23, 2021·Advanced Drug Delivery Reviews·Cláudia AzevedoBruno Sarmento